NASDAQ •
Healthcare •
Biotechnology •
Quote as of 07/02/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization942.14 mln
Float70.63 mln
Earnings Date07/30/2026
EPS
0.19
Overpriced
P / E
72.47
Richly valued
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.81
Likely reliable
Relative Strength
84
/ 100
Strongly outperforming
Debt / Equity
0.43
Low leverage
Business Description
Pharming Group N.V. is a Dutch medical company founded in 1988 and based in Leiden, Netherlands, that creates treatments for rare and serious health conditions. Its two main products are RUCONEST, which helps patients manage sudden episodes of hereditary angioedema, and Joenja, a daily pill designed to treat a rare immune system disorder called activated PI3K delta syndrome. The company sells its products across the United States, Europe, and other markets worldwide, and works alongside Novartis under a formal research and licensing partnership.
